In 1991, a group of experienced European and American haematopathologists, none of whom had previously been involved in the writing of a lymphoma classification, founded the International Lymphoma Study Group (ILSG) for discussion of the problems related to the categorization of such tumours. After completion of two pilot studies, on mantle cell lymphomas [1] and Hodg-kin's disease [2], the group, which in the meantime had expanded (Appendix), decided to tackle the problem of lymphoma classification and formulate a proposal for overcoming the seemingly endless conflicts between the American and European schools [3-13]. In April 1993, the first draft of a new classification was discussed, since all members felt that the limitations of t...
[[abstract]]The World Health Organization (WHO) lymphoma classification has been widely adopted by h...
After publication of the updated World Health Organization (WHO) classification of tumors of hematop...
Lymphoma classification has always played a pivotal role for the management of patients with lymphoi...
The World Health Organization (WHO) publishes classifica-tion handbooks for all neoplastic diseases....
The classification of malignant lymphomas remained controversial for over 30 years. The first scheme...
The latest version of new WHO classification of lymphoid neoplasms is a comprehensive and distinct o...
MALT ” and diffuse large B cell lymphoma In order to communicate data about various lymphomas, it is...
The authors present the guiding principles which led to the development of the Revised European Amer...
For a long time T-cell lymphomas (TCLs) were thought to be limited to southern Japan and some parts ...
The recently proposed Revised European-American Lymphoma Classification represents a serious attempt...
Lymphomas constitute approximately 5% of all malignant neoplasms of the head and neck. They are divi...
Classifications of lymphomas and leukemias have developed from two distinct clinical needs — to unde...
The World Health Organization classification of lymphoid neoplasms updated in 2008 represents a worl...
Background: Non-Hodgkin’s lymphoma (NHL) is pathologically diverse. Epidemiological investigations i...
EW INSIGHTS into the pathogenesis of lymphoid ma- N lignancies have been gained by novel techniques ...
[[abstract]]The World Health Organization (WHO) lymphoma classification has been widely adopted by h...
After publication of the updated World Health Organization (WHO) classification of tumors of hematop...
Lymphoma classification has always played a pivotal role for the management of patients with lymphoi...
The World Health Organization (WHO) publishes classifica-tion handbooks for all neoplastic diseases....
The classification of malignant lymphomas remained controversial for over 30 years. The first scheme...
The latest version of new WHO classification of lymphoid neoplasms is a comprehensive and distinct o...
MALT ” and diffuse large B cell lymphoma In order to communicate data about various lymphomas, it is...
The authors present the guiding principles which led to the development of the Revised European Amer...
For a long time T-cell lymphomas (TCLs) were thought to be limited to southern Japan and some parts ...
The recently proposed Revised European-American Lymphoma Classification represents a serious attempt...
Lymphomas constitute approximately 5% of all malignant neoplasms of the head and neck. They are divi...
Classifications of lymphomas and leukemias have developed from two distinct clinical needs — to unde...
The World Health Organization classification of lymphoid neoplasms updated in 2008 represents a worl...
Background: Non-Hodgkin’s lymphoma (NHL) is pathologically diverse. Epidemiological investigations i...
EW INSIGHTS into the pathogenesis of lymphoid ma- N lignancies have been gained by novel techniques ...
[[abstract]]The World Health Organization (WHO) lymphoma classification has been widely adopted by h...
After publication of the updated World Health Organization (WHO) classification of tumors of hematop...
Lymphoma classification has always played a pivotal role for the management of patients with lymphoi...